Red blood cell alloimmunization in sickle cell disease: Listen to your ancestors

Sally A. Campbell-Lee, Rick A Kittles

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Red blood cell (RBC) alloimmunization occurs in approximately 30% of transfused sickle cell disease patients compared to 2-5% of all transfusion recipients. Because RBC transfusion is an important part of therapy in sickle cell disease, the need for additional antigen matching once alloimmunization occurs is problematic and leads to therapeutic limitations. Thus, identification of risk factors would benefit this patient population. Genome-wide analyses, in particular, methods which take into account genetic ancestry such as admixture mapping, could identify molecular markers which could be used to identify immune responders to transfusion.

Original languageEnglish (US)
Pages (from-to)431-435
Number of pages5
JournalTransfusion Medicine and Hemotherapy
Volume41
Issue number6
DOIs
StatePublished - Dec 17 2014
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Erythrocytes
Erythrocyte Transfusion
Genome
Antigens
Therapeutics
Population

Keywords

  • Alloimmunization
  • Ancestry
  • Genome
  • Sickle cell disease
  • Transfusion

ASJC Scopus subject areas

  • Hematology
  • Immunology and Allergy

Cite this

Red blood cell alloimmunization in sickle cell disease : Listen to your ancestors. / Campbell-Lee, Sally A.; Kittles, Rick A.

In: Transfusion Medicine and Hemotherapy, Vol. 41, No. 6, 17.12.2014, p. 431-435.

Research output: Contribution to journalArticle

@article{5fb25f88f1684ff482b98813b739ac40,
title = "Red blood cell alloimmunization in sickle cell disease: Listen to your ancestors",
abstract = "Red blood cell (RBC) alloimmunization occurs in approximately 30{\%} of transfused sickle cell disease patients compared to 2-5{\%} of all transfusion recipients. Because RBC transfusion is an important part of therapy in sickle cell disease, the need for additional antigen matching once alloimmunization occurs is problematic and leads to therapeutic limitations. Thus, identification of risk factors would benefit this patient population. Genome-wide analyses, in particular, methods which take into account genetic ancestry such as admixture mapping, could identify molecular markers which could be used to identify immune responders to transfusion.",
keywords = "Alloimmunization, Ancestry, Genome, Sickle cell disease, Transfusion",
author = "Campbell-Lee, {Sally A.} and Kittles, {Rick A}",
year = "2014",
month = "12",
day = "17",
doi = "10.1159/000369513",
language = "English (US)",
volume = "41",
pages = "431--435",
journal = "Transfusion Medicine and Hemotherapy",
issn = "1660-3796",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Red blood cell alloimmunization in sickle cell disease

T2 - Listen to your ancestors

AU - Campbell-Lee, Sally A.

AU - Kittles, Rick A

PY - 2014/12/17

Y1 - 2014/12/17

N2 - Red blood cell (RBC) alloimmunization occurs in approximately 30% of transfused sickle cell disease patients compared to 2-5% of all transfusion recipients. Because RBC transfusion is an important part of therapy in sickle cell disease, the need for additional antigen matching once alloimmunization occurs is problematic and leads to therapeutic limitations. Thus, identification of risk factors would benefit this patient population. Genome-wide analyses, in particular, methods which take into account genetic ancestry such as admixture mapping, could identify molecular markers which could be used to identify immune responders to transfusion.

AB - Red blood cell (RBC) alloimmunization occurs in approximately 30% of transfused sickle cell disease patients compared to 2-5% of all transfusion recipients. Because RBC transfusion is an important part of therapy in sickle cell disease, the need for additional antigen matching once alloimmunization occurs is problematic and leads to therapeutic limitations. Thus, identification of risk factors would benefit this patient population. Genome-wide analyses, in particular, methods which take into account genetic ancestry such as admixture mapping, could identify molecular markers which could be used to identify immune responders to transfusion.

KW - Alloimmunization

KW - Ancestry

KW - Genome

KW - Sickle cell disease

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=84918523793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918523793&partnerID=8YFLogxK

U2 - 10.1159/000369513

DO - 10.1159/000369513

M3 - Article

AN - SCOPUS:84918523793

VL - 41

SP - 431

EP - 435

JO - Transfusion Medicine and Hemotherapy

JF - Transfusion Medicine and Hemotherapy

SN - 1660-3796

IS - 6

ER -